Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s Net Profit Rose 40.6% in First Half of 2021

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (600332.SH) reported a net profit of 2.6 billion yuan in the first half of 2021, up 40.6% year-on-year.

Meanwhile, the company posted 36.1 billion yuan in revenue, up 18.6% year-on-year.

At the end of the reporting period, it had 62.6 billion yuan in total assets and 32.6 billion yuan in total liabilities, with a liability-to-asset ratio of 52.1%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.